Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis

Figure 3

Effects of Garidisan on immune cells in peripheral blood. (a) Flow cytometry for CD3⁺CD4⁺ T and CD3⁺CD8⁺ T cells in peripheral blood of experimental animals; (b) flow cytometry for CD4⁺ Th1 and CD4⁺ Th2 cells in peripheral blood of experimental animals; (c) statistical analysis of CD3⁺CD4⁺ T cells/CD3⁺CD8⁺ T cell ratios; (d) statistical analysis of CD4⁺ Th1/CD4⁺ Th2 ratio. Note that (A1) represents CD3⁺CD4⁺ T cells results of experimental animals; (A2) represents CD3⁺CD8⁺ T cells results of experimental animals; (B1) represents CD4⁺ Th1 cells results of experimental animals; (B2) represents CD4⁺ Th2 cells results of experimental animals; (1) represents normal controls; (2) represents the UC model group; (3) represents the low-dose Garidisan group; (4) represents the moderate-dose Garidisan group; (5) represents the high-dose Garidisan group; (6) represents the SASP group; and (7) represents the Bupiyichangwan group; , , and compared with normal controls; , , and compared with the UC model group.

(a)

(b)

(c)

(d)